Rifampin in original treatment of pulmonary tuberculosis. A United States Public Health Service cooperative therapy trial.
D000284:Administration, Oral; D000328:Adult; D000367:Age Factors; D000410:Alanine Transaminase / Q000097:blood; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004361:Drug Tolerance; D004977:Ethambutol / Q000008:administration & dosage / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D012293:Rifampin / Q000008:administration & dosage* / Q000627:therapeutic use; D012737:Sex Factors; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014481:United States; D014492:United States Public Health Service
D004338:Drug Combinations; D004977:Ethambutol; D000410:Alanine Transaminase; D007538:Isoniazid; D012293:Rifampin